Vimarsana
Biggest News Aggregation in the World

Page 25 - Real World Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Real World Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Real World Data Today - Breaking & Trending Today

FDA Roundup: June 27, 2023 - Vimarsana News

FDA Roundup: June 27, 2023

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published new...

Phastar to 'demystify statistical concepts' during DIA Global - Vimarsana News

Phastar to 'demystify statistical concepts' during DIA Global

Phastar is a specialist biometrics contract research organization offering statistical consulting, clinical trial reporting, data management and data science services and will be providing a presentation and running a workshop to give delegates working in any study function a deeper understanding of the interpretation of common statistical terminolgy.

Real-World Data Suggest Long-Term Treatment With Secukinumab Is Safe, Effective - Vimarsana News

Real-World Data Suggest Long-Term Treatment With Secukinumab Is Safe, Effective

Findings are based on a retrospective, multicenter study carried out in Spain.

Source: ajmc.com
Zydus begins Phase IV EVIDENCES-XI Trial To Generate Real World Evidence Of Saroglitazar Mg In NAFLD Patients With Comorbidities - Vimarsana News

Zydus begins Phase IV EVIDENCES-XI Trial To Generate Real World Evidence Of Saroglitazar Mg In NAFLD Patients With Comorbidities

The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52.

Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in NAFLD patients with comorbidities - Vimarsana News

Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in NAFLD patients with comorbidities

Zydus Lifesciences Ltd announced the commencement of Phase of IV Real World Data Registry trial EVIDENCES- XI for Saroglitazar Magnesium in Non-Alcoholic Fatty Liver Disease patients with comorbidities.